Covidien snags CE mark for self-expanding stent

Courtesy of Covidien

Covidien ($COV) has picked up CE mark approval for its EverFlex self-expanding peripheral stent, a device outfitted with the company's Entrust delivery system. Covidien says the one-handed delivery method is more accurate than anything else on the market, and the new device allows for a smaller puncture size during implantation, reducing levels of bleeding and the need for closure devices. EverFlex will begin its rollout in Western Europe next month, according to Covidien. More

Filed Under